Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effecacy of Metformin and Vildagliptin on Cardiometabolic Risk Factors, Metabolic Syndrome, and Diabetic Nephropathy Progression

NCT04485845 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04485845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04485845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effecacy of Metformin and Vildagliptin on Cardiometabolic Risk Factors, Metabolic Syndrome, and Diabetic Nephropathy Progression
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Unknown status
Start date
November 1, 2019
Completion date
September 30, 2020
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, kidney insufficiency, metabolic syndrome